$463 Million is the total value of Aisling Capital LLC's 9 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LOXO | Sell | LOXO ONCOLOGY INC | $348,309,000 | -41.6% | 2,038,920 | -40.7% | 75.27% | -3.9% |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC. | $54,287,000 | -9.9% | 1,990,000 | -11.2% | 11.73% | +48.4% |
| ADMA | ADMA BIOLOGICS INC | $22,407,000 | +37.7% | 3,608,171 | 0.0% | 4.84% | +126.7% | |
| VRAY | Sell | VIEWRAY INC. | $16,249,000 | -68.6% | 1,735,988 | -76.8% | 3.51% | -48.3% |
| TRXC | Sell | TRANSENTERIX INC. | $13,858,000 | -50.3% | 2,389,352 | -62.6% | 3.00% | -18.1% |
| CDTX | CIDARA THERAPEUTICS INC. | $4,493,000 | -15.4% | 1,021,148 | 0.0% | 0.97% | +39.3% | |
| CMRX | CHIMERIX INC. | $1,840,000 | -18.3% | 472,943 | 0.0% | 0.40% | +34.9% | |
| PERNIX THERAPEUTICS HLDGS INCdebt 4.250% 4/0 | $1,095,000 | +0.4% | 2,500,000 | 0.0% | 0.24% | +65.7% | ||
| PTXTQ | PERNIX THERAPEUTICS HLDGS INC | $202,000 | -60.4% | 210,000 | 0.0% | 0.04% | -34.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSENTERIX INC. | 22 | Q3 2019 | 12.1% |
| CHIMERIX INC. | 21 | Q4 2018 | 19.4% |
| ADMA BIOLOGICS INC. | 20 | Q3 2019 | 35.5% |
| LOXO ONCOLOGY INC. | 18 | Q4 2018 | 80.9% |
| AIMMUNE THERAPEUTICS INC. | 17 | Q3 2019 | 68.7% |
| CIDARA THERAPEUTICS INC. | 17 | Q3 2019 | 4.1% |
| AGILE THERAPEUTICS INC. | 16 | Q1 2018 | 5.5% |
| ZELTIQ AESTHETICS INC | 14 | Q3 2017 | 16.3% |
| ESPERION THERAPEUTICS INC NE | 14 | Q3 2017 | 24.9% |
| VERSARTIS INC | 13 | Q2 2017 | 16.2% |
View Aisling Capital LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-13 |
| 13F-HR | 2019-08-08 |
| 13F-HR | 2019-05-07 |
| 13F-HR | 2019-02-11 |
| 13F-HR | 2018-11-05 |
| 13F-HR | 2018-08-13 |
| 13F-HR | 2018-05-14 |
| 13F-HR | 2018-02-07 |
| 13F-HR | 2017-11-09 |
| 13F-HR | 2017-08-14 |
View Aisling Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.